Condition
Lymphoma, Large B-Cell, Diffuse clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Lymphoma, Large B-Cell, Diffuse clinical trials that are recruiting, at sites in 20 countries (most in United States (4), United Kingdom (4), Germany (3)). By phase: Phase 2 (3), Phase 1/2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 20Countries
Newest Lymphoma, Large B-Cell, Diffuse clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| MK-1045 for follicular lymphoma and diffuse large B-cell lymphoma | Phase 1/2 | Los Angeles, California and 53 other locations | Recruiting | Apr 9, 2026 |
| New therapy dose test for people with prior B-cell cancers | Phase 1 | Duarte, California and 50 other locations | Recruiting | Aug 3, 2025 |
| Comparing two treatments for a type of blood cancer called DLBCL | Phase 2 | Mobile, Alabama and 147 other locations | Recruiting | Mar 24, 2025 |
| ImmunoPET imaging for detecting malignant cancers | Phase 2 | Shanghai | Recruiting | Feb 28, 2025 |
| Treatment of B-cell malignancies with ALETA-001 | Phase 1/2 | Birmingham and 6 other locations | Recruiting | Sep 21, 2023 |
| Glofitamab and Polatuzumab with R-CHP for high-risk diffuse large B-cell lymphoma | Phase 2 | Miami, Florida and 2 other locations | Recruiting | Apr 5, 2023 |
All recruiting trials (6)
-
MK-1045 for follicular lymphoma and diffuse large B-cell lymphoma
This trial tests MK-1045 in people with follicular lymphoma or diffuse large B-cell lymphoma to see if the treatment is safe and tolerable and whether the cancer shrinks or disappears.
-
New therapy dose test for people with prior B-cell cancers
This early-phase study tests different doses of LY4152199 to see if it is safe and effective for people who have already been treated for certain B-cell lymphomas.
-
Comparing two treatments for a type of blood cancer called DLBCL
This study is testing whether a new combination of treatments can help people with a specific type of blood cancer feel better compared to the standard treatment.
-
ImmunoPET imaging for detecting malignant cancers
This study is testing a new imaging method to see if it can better detect certain types of cancer in patients who have or might have these diseases.
-
Treatment of B-cell malignancies with ALETA-001
This study is testing a new treatment called ALETA-001 to see if it can help people with relapsed non-Hodgkin lymphoma who didn't respond well to previous therapies.
-
Glofitamab and Polatuzumab with R-CHP for high-risk diffuse large B-cell lymphoma
This will test whether adding the immunotherapies glofitamab and polatuzumab to standard R-CHP chemotherapy helps adults with previously untreated high-risk diffuse large B-cell lymphoma.
Related topics
Quick answers
How many Lymphoma, Large B-Cell, Diffuse clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 20 countries. The most sites are in United States (4 trials), United Kingdom (4 trials), Germany (3 trials), Italy (3 trials), Poland (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.